NGNE
NeurogeneยทNASDAQ
--
--(--)
--
--(--)
NGNE Profile
Neurogene Inc.
A biopharmaceutical company using protein design technology to develop immunotherapies
535 W 24th St., 5th Floor, New York, NY 10011
--
Neurogene Inc., originally incorporated in Delaware in May 2007 under the name Aquinox Pharmaceuticals, adopted its current name in December 2023 after a series of mergers and name changes. The company is a clinical-stage biotechnology company that leverages its proprietary EXACT transgenic regulation technology to focus on the development of genetic medicines for rare neurological diseases.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
